Trademark: 90642191
Word
XGENE PHARMACEUTICAL
Status
Pending
Status Code
730
Status Date
Tuesday, November 7, 2023
Serial Number
90642191
Mark Type
3000
Filing Date
Tuesday, April 13, 2021
Published for Opposition
Tuesday, March 28, 2023

Trademark Owner History
XGENE PHARMACEUTICAL INC. - Owner At Publication

Classifications
5 Vaccines; Medicines for human purposes, namely, medicines for treatment of cancer; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Pain relief medication; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Antibiotics; Chemico-pharmaceutical preparations for treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating skin disorders; Dermatological pharmaceutical products; Herbicide for agricultural use; Pesticides for agricultural use; Fungicides for agricultural use; Medicines for veterinary purposes, namely, killing insects
42 Chemical research; Chemical analysis; Chemistry consultation; Cosmetic research; Biological research; Scientific research; Scientific research and development; Research and development of new products for others; Medical research; Technological research in the field of medical instruments; Product quality testing; Scientific research for medical purposes in the area of cancerous diseases
The mark consists of a design consisting of a series of geometric shapes, together forming a hexagon. Beginning at the top of the design and moving counter clockwise, the shapes are a blue triangle, a blue diamond, two green diamonds and a sixth negative space bordered by the letter X in term XGENE, which is at the top right of the design element with the letter X in the colors blue and green, and the letters GENE in the color blue. The green term PHARMACEUTICAL is to the right of the design image and beneath the term XGENE.
The color(s) blue and green is/are claimed as a feature of the mark.
"PHARMACEUTICAL"

Trademark Events
Nov 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 7, 2023
Sou Extension 1 Granted
Nov 7, 2023
Sou Extension 1 Filed
Nov 7, 2023
Sou Teas Extension Received
May 23, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 28, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 28, 2023
Published For Opposition
Mar 8, 2023
Notification Of Notice Of Publication E-Mailed
Feb 22, 2023
Approved For Pub - Principal Register
Jan 17, 2023
Teas/Email Correspondence Entered
Jan 17, 2023
Correspondence Received In Law Office
Jan 17, 2023
Teas Response To Office Action Received
Jul 18, 2022
Notification Of Non-Final Action E-Mailed
Jul 18, 2022
Non-Final Action E-Mailed
Jul 18, 2022
Non-Final Action Written
Jun 2, 2022
Teas/Email Correspondence Entered
Jun 2, 2022
Correspondence Received In Law Office
Jun 2, 2022
Teas Response To Office Action Received
Dec 3, 2021
Notification Of Non-Final Action E-Mailed
Dec 3, 2021
Non-Final Action E-Mailed
Dec 3, 2021
Non-Final Action Written
Dec 3, 2021
Assigned To Examiner
Jul 21, 2021
Notice Of Design Search Code E-Mailed
Jul 20, 2021
New Application Office Supplied Data Entered
Apr 16, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24